LAURA ASHLEY ZINN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TARPON SPRINGS, FL NPI 1760961007

General Payments — all program years on this page

$2,753.03

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $797.01 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $764.7418
Education $32.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $623.8219
2022 $709.3117
2023 $622.8919
2024 $797.0119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080648083 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $30.67 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080648125 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $13.77 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081712636 Lexicon Pharmaceuticals, Inc. $16.71 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087363850 Novartis Pharmaceuticals Corporation $42.41 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092447484 Boston Scientific Corporation $16.83 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092447486 Boston Scientific Corporation $22.41 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100345170 Novo Nordisk Inc $32.27 02/19/2024 Education Undisputed 01/23/2026 View at CMS
1100471005 Novo Nordisk Inc $19.35 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145642 Boehringer Ingelheim Pharmaceuticals, Inc. $9.63 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145644 Boehringer Ingelheim Pharmaceuticals, Inc. $26.38 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145646 Boehringer Ingelheim Pharmaceuticals, Inc. $26.51 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145648 Boehringer Ingelheim Pharmaceuticals, Inc. $28.61 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145650 Boehringer Ingelheim Pharmaceuticals, Inc. $86.25 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145652 Boehringer Ingelheim Pharmaceuticals, Inc. $92.55 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125259341 Abbott Laboratories $12.55 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125259345 Abbott Laboratories $154.39 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125259349 Abbott Laboratories $120.91 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131383175 PFIZER INC. $23.45 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132313721 SCPHARMACEUTICALS INC. $21.36 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.